NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic‑focused healthcare company, today announced that its inaugural 2022 Corporate Transparency Report is now available under the Investors section of the Company…
Author: Business Wire
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
LOS ANGELES & EMERYVILLE, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that they have entered into a definitive agreement under w…
Glaukos Announces Executive Leadership Changes
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced sever…
Bosma Enterprises® Hits Pandemic Milestone, Moves to Online Sales
INDIANAPOLIS–(BUSINESS WIRE)–Today, Bosma Enterprises® announced it has distributed more than 1.4 billion exam and surgical gloves since the beginning of the global COVID-19 pandemic. This benchmark comes on the heels of Bosma launching its e-commerc…
UIW Study Finds Special Glasses Help Color Blind See Colors Better
SAN ANTONIO–(BUSINESS WIRE)– #UCDavis–A groundbreaking new study found that EnChroma glasses enhance color vision for those with the most common types of color blindness.
Worldwide Eyewear Industry to 2027 – Featuring Luxottica Group, Essilor and Safilo Group Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global eyewear market size reached US$ 140 Billion in 2021. L…
Global Excimer & Femtosecond Ophthalmic Lasers Markets, 2021-2028: Untapped Potential of Emerging Economies & Large Number of Product Approvals and Launches – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Excimer & Femtosecond Ophthalmic Lasers Market Forecast to 2028 – COVID-19 Impact and Global Analysis” report has been added to ResearchAndMarkets.com’s offering. The excimer & femtosecond ophthalmic lasers market …
HPO Achieves Innovation Milestone: 100 Patents
CHARLOTTE, N.C.–(BUSINESS WIRE)–HPO Reaches a Milestone in Innovation Protection
National Association for the Employment of People Who Are Blind Elects Jeffrey Mittman as President
INDIANAPOLIS–(BUSINESS WIRE)–The National Association for the Employment of People who are Blind (NAEPB) today announced the election of Jeffrey Mittman as its new president. Mittman currently serves as the President & CEO of Bosma, an Indianapol…
Neura Health Raises $2.2M to Improve Access and Quality of Care for Neurologic Conditions
NEW YORK–(BUSINESS WIRE)–Neura Health Raises $2.2M to Improve Access and Quality of Care for Neurologic Conditions
Global Protective Eyewear Market Report 2022: Market to Reach $3.1 Billion by 2026 – High-Growth Opportunities in the Military Sector – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Protective Eyewear – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Protective Eyewear Market to Reach $3.1 Billion by 2026 The global market for Protective Eye…
Aldeyra Therapeutics Announces Publication of Phase 2 Clinical Trial of Reproxalap in Allergen Chamber Model
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced that results from the randomi…
Glaukos Corporation to Release Fourth Quarter and Full Year 2021 Financial Results after Market Close on February 22
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release four…
20/20 Onsite Kicks off the New Year With a New Look and Expansion to Three New Mobile Vision Clinics
BOSTON–(BUSINESS WIRE)–20/20 Onsite, a Boston-based mobile eye health provider has launched three new Mobile Vision Clinics and updated its look to help fulfill its mission of providing high-quality, accessible vision care to patients across the coun…
FDA Approves Genentech’s Vabysmo, the First Bispecific Antibody for the Eye, to Treat Two Leading Causes of Vision Loss
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Vabysmo™ (faricimab-svoa) for the treatment of wet, or neov…
Théa to Acquire Branded Ophthalmic Products from Akorn, Expanding Théa’s Presence into the U.S. Eye Care Industry
CLERMONT-FERRAND, France–(BUSINESS WIRE)–Laboratoires Théa SAS (“Théa”), Europe’s leading independent pharmaceutical company specializing in the research, development, and commercialization of eye-care products, today announced an agreement to purcha…
NovaBay Pharmaceuticals Announces Changes to Its Board of Directors
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announce…
Insights on the Optical Preclinical Imaging Global Market to 2027 – Featuring Agilent Technologies, INDEC Systems and Mediso Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Preclinical Imaging Market Research Report by Product Type, by End-use, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Op…
Ted Davis to Succeed Amy Tseng as President and CEO of TissueTech
MIAMI–(BUSINESS WIRE)–TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue products, named Ted Davis as its new president and CEO.
Melanoma Research Alliance Statement on FDA Approval of Tebentafusp, the First Drug for Treating Metastatic Uveal Melanoma
WASHINGTON–(BUSINESS WIRE)–The Melanoma Research Alliance (MRA) released the following statements from MRA Chief Science Officer Marc Hurlbert, PhD and MRA President & CEO Michael Kaplan on the Food & Drug Administration approval of tebentafu…